These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. FDA triple header. Food and Drug Administration. Smart T GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986 [TBL] [Abstract][Full Text] [Related]
10. [What should be done after needlestick injuries with possible HIV exposure?]. Marcus U Fortschr Med; 1996 Feb; 114(4):23-4. PubMed ID: 8852682 [No Abstract] [Full Text] [Related]
12. Protease inhibitors shine in triple combinations. AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243 [TBL] [Abstract][Full Text] [Related]
13. HIV's Achilles' heel. Drugs and education are starting to slow the AIDS virus. Beardsley T Sci Am; 1996 Sep; 275(3):16, 18. PubMed ID: 8701287 [No Abstract] [Full Text] [Related]
16. Lamivudine (3TC) approved for combination use with AZT. James JS AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049 [TBL] [Abstract][Full Text] [Related]
17. Top AIDS researchers' strategy for antiretroviral treatment. AIDS Alert; 1996 Sep; 11(9):97-100. PubMed ID: 11363728 [TBL] [Abstract][Full Text] [Related]
18. New developments in antiretroviral drug therapy for HIV-1 infections. Johnson VA AIDS Clin Rev; 1995-1996; ():305-46. PubMed ID: 7488558 [No Abstract] [Full Text] [Related]
19. Triple combination superior to double combination. Grodeck B Posit Aware; 1995; ():6. PubMed ID: 11362210 [TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors and prevention of cross resistance. Levin J AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]